Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma

Maurizio Soresi; Natale D'Alessandro; Giuseppe Montalto; Lydia Giannitrapani; Melchiorre Cervello; null La Rosa; null Virruso; Marzia La Rosa; Lucrezia Virruso

Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma

Maurizio Soresi, Natale D'Alessandro, Giuseppe Montalto, Lydia Giannitrapani, Melchiorre Cervello, La Rosa, Virruso, Marzia La Rosa, Lucrezia Virruso

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Article › peer review

25 Citazioni (Scopus)

Abstract

Interleukin-6 plays a central role in regulating the immune system, hematopoiesis, and acute phase reaction. It interacts with a receptor complex consisting of a specific ligand-binding protein (IL-6R, gp80) and a signal transduction protein (gp130). In this report, serum levels of IL-6 and a soluble form of the interleukin-6 receptor (sIL-6R) were evaluated in patients with hepatocellular carcinoma. The correlation between IL-6 and sIL-6R values, the stage of hepatocellular carcinoma, and main liver function tests was also studied.

Lingua originale	English
pagine (da-a)	46-52
Numero di pagine	7
Rivista	Annals of the New York Academy of Sciences
Volume	963
Stato di pubblicazione	Published - 2002

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2800.2800???
???subjectarea.asjc.1300.1300???
???subjectarea.asjc.1200.1207???

Altri file e collegamenti

OA Link

Cita questo

@article{4b36fb7a02e943758ec660e222d397a0,

title = "Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma",

abstract = "Interleukin-6 plays a central role in regulating the immune system, hematopoiesis, and acute phase reaction. It interacts with a receptor complex consisting of a specific ligand-binding protein (IL-6R, gp80) and a signal transduction protein (gp130). In this report, serum levels of IL-6 and a soluble form of the interleukin-6 receptor (sIL-6R) were evaluated in patients with hepatocellular carcinoma. The correlation between IL-6 and sIL-6R values, the stage of hepatocellular carcinoma, and main liver function tests was also studied.",

author = "Maurizio Soresi and Natale D'Alessandro and Giuseppe Montalto and Lydia Giannitrapani and Melchiorre Cervello and {La Rosa} and Virruso and {La Rosa}, Marzia and Lucrezia Virruso",

year = "2002",

language = "English",

volume = "963",

pages = "46--52",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma

AU - Soresi, Maurizio

AU - D'Alessandro, Natale

AU - Montalto, Giuseppe

AU - Giannitrapani, Lydia

AU - Cervello, Melchiorre

AU - La Rosa, null

AU - Virruso, null

AU - La Rosa, Marzia

AU - Virruso, Lucrezia

PY - 2002

Y1 - 2002

N2 - Interleukin-6 plays a central role in regulating the immune system, hematopoiesis, and acute phase reaction. It interacts with a receptor complex consisting of a specific ligand-binding protein (IL-6R, gp80) and a signal transduction protein (gp130). In this report, serum levels of IL-6 and a soluble form of the interleukin-6 receptor (sIL-6R) were evaluated in patients with hepatocellular carcinoma. The correlation between IL-6 and sIL-6R values, the stage of hepatocellular carcinoma, and main liver function tests was also studied.

AB - Interleukin-6 plays a central role in regulating the immune system, hematopoiesis, and acute phase reaction. It interacts with a receptor complex consisting of a specific ligand-binding protein (IL-6R, gp80) and a signal transduction protein (gp130). In this report, serum levels of IL-6 and a soluble form of the interleukin-6 receptor (sIL-6R) were evaluated in patients with hepatocellular carcinoma. The correlation between IL-6 and sIL-6R values, the stage of hepatocellular carcinoma, and main liver function tests was also studied.

UR - http://hdl.handle.net/10447/198026

M3 - Article

SN - 0077-8923

VL - 963

SP - 46

EP - 52

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

ER -

Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo